Medication info
Lipiroo Jeong 10 mg (Atorvastatin Calcium Trihydrate)

Lipiroo Jeong 10 mg (Atorvastatin Calcium Trihydrate)

Prescription medicationTabletOral
Ingredient · strength
Atorvastatin Calcium Trihydrate›10.85mg / 1 tablet
Manufacturer / importer
Jongkundang Co., Ltd.
Appearance
White egg-shaped film-coated tablets
Packaging
30 tablets/PTP [(10 tablets/PTP package x 3)], 30 tablets/bottle, 100 tablets/bottle
Approval status
Active

MFDS item code 200802327 · Notified 2008.02.29 · Insurance code 643304610

Summary

Main use
Improvement of hyperlipidemia; prevention of cardiovascular diseases (myocardial infarction, stroke, etc.)
Who takes it
Adults · Children
Adult dose
Patients receiving atorvastatin should follow a standard cholesterol-lowering diet before and during treatment. The medication may be taken at any time of day, with or without food. 1. Hyperlipidemia The recommended initial dose is 10 mg of atorvastatin once daily; however, for patients requiring a greater reduction in LDL cholesterol, treatment may be initiated at 20 mg or 40 mg once daily (only when a reduction in LDL cholesterol of 45 % or more is required). This medication is administered once daily at doses ranging from 10 ~ 80 mg. The initial and maintenance doses of this medication should be individualized according to patient characteristics, taking into consideration treatment goals and response. Lipid levels should be analyzed within 2 ~ 4 weeks after treatment initiation and/or dose titration, and the dose should be adjusted accordingly. Because the goal of treatment is to lower LDL cholesterol, it is recommended that LDL cholesterol be used at the start of treatment and when assessing response to treatment. However, if LDL cholesterol levels are unavailable, total cholesterol levels should be used to monitor response to treatment. Patients with homozygous familial hypercholesterolemia This medication is administered at a dose of 10 ~ 80 mg once daily, in combination with other lipid-lowering treatments (e.g., LDL apheresis), or when such treatments are not available. ○ Patients with renal impairment: Renal disease does not affect the plasma concentration of atorvastatin or its LDL cholesterol-lowering effect; therefore, no dose adjustment is necessary. ○ Older adults: The efficacy and safety in patients aged 70 years or older are similar to those in the general adult patient population.
Child dose
Pediatric patients with heterozygous familial hypercholesterolemia (10 ~ 17 years): The recommended initial dose is 10 mg of this medication once daily, and the recommended maximum dose is 20 mg once daily (there are no clinical data on doses of this medication higher than 20 mg in pediatric patients). The dose should be adjusted at intervals of 4 weeks or longer.

Ingredients

Manufacturer
Jongkundang Co., Ltd.

Efficacy & effects

Improvement of hyperlipidemia; prevention of cardiovascular diseases (myocardial infarction, stroke, etc.)

  • Coronary heart disease
  • myocardial infarction
  • stroke
  • vascular interventions
  • chronic stable angina
  • retinopathy
  • albuminuria
  • hypertension
  • congestive heart failure
  • angina
  • hyperlipidemia
  • primary hypercholesterolemia
View approved original text

This medication helps reduce the risk of cardiovascular diseases. It lowers the risk of myocardial infarction and stroke in adults with multiple risk factors such as advanced age, smoking, hypertension, and family history, as well as in patients with type 2 diabetes, and also reduces the risks of vascular interventions and angina. Additionally, it is used as an adjunct to diet for patients with hyperlipidemia to lower cholesterol and triglyceride levels and raise good cholesterol (HDL). Particularly, it is utilized in pediatric patients with familial hypercholesterolemia to effectively reduce total cholesterol and LDL cholesterol levels. This medication is used to improve cardiovascular health and control blood lipid levels to prevent heart diseases.

How to take

Adult dose

Patients receiving atorvastatin should follow a standard cholesterol-lowering diet before and during treatment. The medication may be taken at any time of day, with or without food. 1. Hyperlipidemia The recommended initial dose is 10 mg of atorvastatin once daily; however, for patients requiring a greater reduction in LDL cholesterol, treatment may be initiated at 20 mg or 40 mg once daily (only when a reduction in LDL cholesterol of 45 % or more is required). This medication is administered once daily at doses ranging from 10 ~ 80 mg. The initial and maintenance doses of this medication should be individualized according to patient characteristics, taking into consideration treatment goals and response. Lipid levels should be analyzed within 2 ~ 4 weeks after treatment initiation and/or dose titration, and the dose should be adjusted accordingly. Because the goal of treatment is to lower LDL cholesterol, it is recommended that LDL cholesterol be used at the start of treatment and when assessing response to treatment. However, if LDL cholesterol levels are unavailable, total cholesterol levels should be used to monitor response to treatment. Patients with homozygous familial hypercholesterolemia This medication is administered at a dose of 10 ~ 80 mg once daily, in combination with other lipid-lowering treatments (e.g., LDL apheresis), or when such treatments are not available. ○ Patients with renal impairment: Renal disease does not affect the plasma concentration of atorvastatin or its LDL cholesterol-lowering effect; therefore, no dose adjustment is necessary. ○ Older adults: The efficacy and safety in patients aged 70 years or older are similar to those in the general adult patient population.

Child dose

Pediatric patients with heterozygous familial hypercholesterolemia (10 ~ 17 years): The recommended initial dose is 10 mg of this medication once daily, and the recommended maximum dose is 20 mg once daily (there are no clinical data on doses of this medication higher than 20 mg in pediatric patients). The dose should be adjusted at intervals of 4 weeks or longer.

Precautions

This medication may cause muscle-related abnormalities; therefore, treatment should be discontinued immediately in case of severe muscle pain or weakness, or a significant increase in creatine kinase levels. Patients with poor liver function or a history of liver disease should not use this medication and must undergo regular liver function tests while on treatment. This medication should not be administered to women who are pregnant, who may become pregnant, or who are breastfeeding. Children under 10 years of age and patients with certain genetic lactose metabolism disorders should also not take this medication. Particular caution is needed for alcoholics, patients with reduced kidney function, the elderly, and those with a history of muscle disorders, and careful monitoring for muscle-related abnormal symptoms is required. This medication may interact with other drugs; hence, dosage adjustments or discontinuation may be necessary, especially when taken with certain antibiotics, antifungals, HIV treatments, and some lipid-lowering agents. If symptoms such as muscle pain, fatigue, or fever appear while taking this medication, the healthcare provider must be notified immediately, and discontinuation of the medication may be necessary if symptoms are severe. Taking this medication with grapefruit juice may increase blood concentration, raising the risk of side effects, so grapefruit juice should be avoided. Appropriate contraception should be used during the course of this medication, and if pregnancy is confirmed, treatment should be stopped immediately. In the case of children or elderly patients, the effects and side effects of the medication may differ, so careful monitoring is required. There is no specific detoxification method for overdose; however, appropriate treatment should be administered based on symptoms while monitoring liver function and muscle enzyme levels. This medication should be stored out of reach of children and kept in its original container to maintain quality.

Side effects

  • Weakness
  • lethargy
  • chest pain
  • peripheral edema
  • fatigue
  • fever
  • nasopharyngitis
  • hyperglycemia
  • hypoglycemia
  • weight gain
Show 172 more
  • loss of appetite
  • constipation
  • abdominal distension
  • dyspepsia
  • nausea
  • diarrhea
  • abdominal pain
  • vomiting
  • belching
  • pancreatitis
  • pharyngitis
  • laryngitis
  • epistaxis
  • insomnia
  • nightmares
  • headache
  • dizziness
  • paresthesia
  • sensory loss
  • taste alteration
  • amnesia
  • peripheral neuropathy
  • myalgia
  • arthralgia
  • limb pain
  • musculoskeletal pain
  • muscle cramps
  • joint swelling
  • back pain
  • neck pain
  • muscle fatigue
  • complication due to rupture
  • myopathy
  • myositis
  • rhabdomyolysis
  • tendon disorders
  • muscle rupture
  • lupus-like syndrome
  • immune-mediated necrotizing myopathy
  • thrombocytopenia
  • vasculitis
  • allergic reactions
  • anaphylaxis
  • hepatitis
  • cholestasis
  • liver failure
  • blurred vision
  • visual impairment
  • tinnitus
  • hearing loss
  • urticaria
  • skin rash
  • itching
  • hair loss
  • angioedema
  • vascular neurogenic edema
  • erythema multiforme
  • blistering dermatitis
  • Stevens-Johnson syndrome
  • toxic epidermal necrolysis
  • gynecomastia
  • abnormal liver function test
  • elevated serum CK
  • positive urinary leukocytes
  • vomiting
  • abdominal abnormalities
  • hepatitis
  • pancreatitis
  • cholestasis
  • cholestatic jaundice
  • abnormal liver function testing
  • gastroenteritis
  • enteritis
  • dry mouth
  • rectal bleeding
  • esophagitis
  • belching
  • glossitis
  • oral ulcers
  • stomatitis
  • gallbladder pain
  • cheilitis
  • peptic ulcer
  • dysphagia
  • melena
  • gingival bleeding
  • acute urinary retention
  • bronchitis
  • rhinitis
  • pneumonia
  • dyspnea
  • asthma
  • sensory disturbances
  • vertigo
  • phototoxic reactions
  • drowsiness
  • forgetfulness
  • abnormal dreams
  • decreased libido
  • emotional instability
  • motor coordination ataxia
  • torticollis
  • facial paralysis
  • hyperkinesis
  • depression
  • increased tension
  • myositis
  • muscle disorders
  • arthritis
  • bursitis
  • tenosynovitis
  • myasthenia gravis
  • tendon contraction
  • elevated serum myoglobin
  • contact dermatitis
  • skin dryness
  • sweating
  • acne
  • eczema
  • seborrhea
  • skin ulcer
  • erectile dysfunction
  • urinary tract infection
  • frequent urination
  • cystitis
  • hematuria
  • dysuria
  • kidney stones
  • nocturia
  • epididymitis
  • fibrocystic breast disease
  • vaginal bleeding
  • albuminuria
  • breast enlargement
  • cervical discharge
  • nephritis
  • urinary incontinence
  • urinary retention
  • urgent urination
  • abnormal ejaculation
  • uterine bleeding
  • discolored urine
  • hypoglycemia
  • increased appetite
  • neurogenic edema
  • chest pain
  • angina
  • facial swelling
  • fever
  • neck stiffness
  • generalized edema
  • amblyopia
  • dry eyes
  • refractive disorder
  • hemorrhage in the eye
  • hearing loss
  • glaucoma
  • taste distortion
  • taste loss
  • taste alteration
  • leukopenia
  • anemia
  • decreased testosterone
  • increased cholinesterase
  • elevated TSH
  • elevated ACTH
  • decreased aldosterone
  • elevated potassium
  • increased BUN
  • cerebral infarction
  • palpitations
  • tachycardia

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a tightly closed container to prevent exposure to air and moisture and should be kept at a temperature between 1 and 30 degrees Celsius. Proper storage helps maintain the effectiveness of the medication for a longer period.

Appearance and packaging

Appearance

White egg-shaped film-coated tablets

Package unit

30 tablets/PTP [(10 tablets/PTP package x 3)], 30 tablets/bottle, 100 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.